D.E. Shaw & Co
EW icon

D.E. Shaw & Co’s Edwards Lifesciences EW Stock Holding History

D.E. Shaw & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,200
Closed -$522K – 4449
2025
Q1 		$522K Buy
+7,200
New +$515K ﹤0.01% 3484
2023
Q1 		– Sell
-42,800
Closed -$3.19M – 4561
2022
Q4 		$3.19M Hold
42,800
– – ﹤0.01% 2528
2022
Q3 		$3.54M Buy
+42,800
New +$4.12M ﹤0.01% 2456
2021
Q1 		– Sell
-88,200
Closed -$8.05M – 4170
2020
Q4 		$8.05M Hold
88,200
– – 0.01% 1511
2020
Q3 		$7.04M Hold
88,200
– – 0.01% 1462
2020
Q2 		$6.1M Sell
88,200
-5,100
-5% -$362K 0.01% 1515
2020
Q1 		$5.87M Sell
93,300
-21,300
-19% -$1.54M 0.01% 1349
2019
Q4 		$8.91M Buy
114,600
+22,200
+24% +$1.73M 0.01% 1282
2019
Q3 		$6.77M Buy
+92,400
New +$6.49M 0.01% 1423
2016
Q1 		– Sell
-60,000
Closed -$1.58M – 3526
2015
Q4 		$1.58M Hold
60,000
– – ﹤0.01% 2315
2015
Q3 		$1.42M Hold
60,000
– – ﹤0.01% 2348
2015
Q2 		$1.42M Sell
60,000
-67,200
-53% -$1.52M ﹤0.01% 2449
2015
Q1 		$3.02M Sell
127,200
-4,200
-3% -$94.2K ﹤0.01% 1729
2014
Q4 		$2.79M Hold
131,400
– – ﹤0.01% 1998
2014
Q3 		$2.24M Hold
131,400
– – ﹤0.01% 2155
2014
Q2 		$1.88M Sell
131,400
-226,800
-63% -$3.07M ﹤0.01% 2360
2014
Q1 		$4.43M Sell
358,200
-3,000
-0.8% -$34.6K 0.01% 1694
2013
Q4 		$3.96M Buy
361,200
+139,800
+63% +$1.58M 0.01% 1897
2013
Q3 		$2.57M Buy
+221,400
New +$2.59M ﹤0.01% 2208

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

D.E. Shaw & Co's EW Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 89,515 shares — an estimated $7.63M sold.

D.E. Shaw & Co first reported a position in EW in Q2 2013 and held it in 45 quarters. The position peaked at $251M in Q1 2023. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 89,515 Edwards Lifesciences shares in Q1 2026, an estimated $7.63M.
  • D.E. Shaw & Co first reported a position in Edwards Lifesciences in Q2 2013 and held it in 45 quarters.
  • D.E. Shaw & Co's Edwards Lifesciences position peaked at $251M in Q1 2023.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.